Papers: 10.1371/journal.pmed.1003038

https://doi.org/10.1371/journal.pmed.1003038

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

Cited by: 24
Author(s): Fatima Laher, Zoe Moodie, Kristen W. Cohen, Nicole Grunenberg, Linda‐Gail Bekker, Mary Allen, Nicole Frahm, Nicole L. Yates, Lynn Morris, Mookho Malahleha, Kathryn Mngadi, Brodie Daniels, Craig Innes, Kevin O. Saunders, Shannon Grant, Chenchen Yu, Peter B. Gilbert, Sanjay Phogat, Carlos A. DiazGranados, Marguerite Koutsoukos, Olivier Van Der Meeren, Carter Bentley, Nonhlanhla N. Mkhize, Michael Pensiero, Vishu Mehra, James G. Kublin, Lawrence Corey, David C. Montefiori, Glenda Gray, M. Juliana McElrath, Georgia D. Tomaras
Published: over 6 years ago

Software Mentions 1